Clinical Trial Update: The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

View source ↗

Summary

Clinical trial update investigating the combination of a GnRH analogue with an aromatase inhibitor in receptor-positive premenopausal women with advanced breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)
• GnRH analogue (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Advanced Breast Cancer | Status: UNKNOWN